Delivery Order SPE2DB22D3011-SPE2DB25FQ2KP
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,501.55 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes, with a ceiling value of $7,592.10. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5ML) valued at $1,044.92 under a firm fixed price contract with an ultimate completion date of August 28, 2025. This non-set-aside award represents a single delivery order positioned as a child contract, leveraging the company's extensive pharmaceutical supply capabilities and established federal procurement relationships. The vaccine delivery will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $18,399.97 with a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small component of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $4,470.50 and is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains operations as...
- The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,661.00 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on July 29, 2025, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,306.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, with an ultimate completion date of August 6, 2025. This non-set-aside contract was awarded on August 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5 mL) valued at $2,636.60 on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's broader...